Over months, that adds up to needing meaningfully fewer calories to maintain weight, which makes plateaus more likely and rebounds more probable if you stop the medication
This modulation of the reward system could help individuals with BED regain control over their eating behaviors and reduce the compulsive nature of binge eating (Alhadeff et al., 2019)
We have fully verified that the MNs/GLP-1RAs@NPs-WYRGRL did not show obvious toxicity, indicating its excellent biological safety through in vivo experiments
These insights can support a more informed conversation with your provider about expected tolerability and optimal dosing strategy, though genetic predisposition does not predict exact medication response
The two trials are each expected to enroll 1,840 patients who will be randomly assigned to receive either once-a-day oral semaglutide (tapered to 14 mg) or placebo for 173 weeks
Patients taking Ozempic often experience appetite suppression and early satiety, which can lead to lower caloric consumption